Loading provider…
Loading provider…
Urology Physician in New York, NY
NPI: 1215916697Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get MD Guido's Phone Numberphone_androidMobile
Get MD Guido's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1989 - 2026
NJ State Medical License
1986 - 2025

American Board of Urology
Urology
NYU Grossman School of Medicine
med.nyu.edu
Residency • Urology
1984 - 1988
Icahn School of Medicine at Mount Sinai (Cabrini)
Residency • Surgery
1982 - 1984
Cairo University School of Medicine
Medical School
Until 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 311 | 487 |
| 2 | 99212Established patient outpatient visit, total time 10-19 minutes | 79 | 84 |
| 3 | 52224Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope | 55 | 58 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 45 | 45 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 36 | 40 |
Authors: Harry Herr
Journal: Clin Cancer Res
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
Authors: Viktor Soukup, Marko Babjuk, Joaquim Bellmunt, Guido Dalbagni, Gianluca Giannarini, Oliver Hakenberg, Harry Herr, Eric Lechevallier, Maria Ribal
Publication Date: 2012-02-25
Lead Sponsor: Medical Enterprises Ltd.
Intervention / Treatment: COMBINATION_PRODUCT: Synergo® RITE + MMC
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Gemcitabine, DRUG: Bacillus Calmette-Guérin (BCG)
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Novartis Pharmaceuticals, New York University, University of Hawaii
Intervention / Treatment: DRUG: Everolimus and Intravesical Gemcitabine